Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study. - Aguirre LE; Stone RM; DeAngelo DJ; Stahl M (Blood cancer journal, 2025)